The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age5-21
SponsorBoston Children's Hospital

About this trial

Using a four-week randomized, crossover study design, we will assess the impact of 2 weeks of a high bile acid-binding blenderized diet, compared to 2 weeks of a low bile acid-binding blenderized diet, on gastric and salivary bile acid concentrations within individual participants. Four weeks of an amino acid formula will be a comparator group.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

receive blenderized feeds or will start receiving blenderized feeds

have no known allergies to ingredients in blenderized feeds;

receive their bolus feeds within 30 minutes or less

can receive their feeds by syringe push

Disqualifiers

have undergone anti-reflux surgery

receive post-pyloric feeds

are allergic to any component of the administered diets

cannot receive their gastrostomy feeds over 30 minutes

Trial design

Design model

Crossover

Treatments tested in this trial

  • Low bile acid binding blenderized diet

    Drug

    Low bile acid binding blenderized diet administered for 2 weeks

  • High bile acid binding blenderized diet

    Drug

    High bile acid binding blenderized diet administered for 2 weeks

Treatment groups

66 Participants
are divided into 3 treatment groups
Group A: Low bile binding then high bile binding blenderized dietsExperimental treatment 2 interventions
Group B: High bile binding then low bile binding blenderized dietsExperimental treatment 2 interventions
Group C: amino acid-based formulaNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Gastric bile acid concentration

differences in total gastric bile acid concentrations at the end of each diet period

Time frame
after 2 weeks on each of 2 diets (cross-over design)

Secondary outcomes

1

Gastric bile acid concentration

changes in gastric bile acid composition (e.g., change in the proportion of gastric conjugated:unconjugated bile acid) between diet periods

Time frame
after 2 weeks on each of 2 diets (cross-over design)
2

Symptom scores

changes in symptoms over the two weeks between diet periods

Time frame
after 2 weeks on each of 2 diets (cross-over design)
3

Salivary and stool bile acid concentrations

changes in the total salivary and stool BA concentrations between diet periods;

Time frame
after 2 weeks on each of 2 diets (cross-over design)
4

Serum complement 4 (C4)

changes in serum C4 between diet periods

Time frame
after 2 weeks on each of 2 diets (cross-over design)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: